Laurent Chardonnet is Chief Financial Officer of Prelude Therapeutics. Prior to Prelude, he served as Senior Vice President, Chief Financial Officer at Axcella Health. Prior to Axcella, he spent 15 years at Incyte Corporation where he held roles of increasing responsibility including Vice President Finance, Treasurer and Principal Accounting Officer, Head of Finance and Administration for the company’s European division, and Vice President of Alliances and Global Strategy. Mr. Chardonnet received his Master of Business Administration from Vanderbilt University and his initial business degree from the Institut Supérieur de Gestion in Paris.
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.